[1]Kalvakolanu DV. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression [J]. Cytokine Growth Factor Rev, 2004,15(2-3): 169-194.[2]Angell JE, Lindner DJ, Shapiro PS, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach[J]. J Biol Chem, 2000, 275(43): 33416-33426.
[3]Chidambaram NV, Angell JE, Ling W, et al. Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death[J]. J Interferon Cytokine Res, 2000, 20(7): 661-665.
[4]Huang G, Lu H, Hao A, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I[J]. Mol Cell Biol, 2004, 24(19): 8447-8456.
[5]Achache H,Revel A. Endometrial receptivity markers,the journey to successful embryo implantation[J].Hum Reprod Update,2006,12(6):731-746.
[6]Salamonsen LA, Nie G, Hannan NJ, et al. (2009) Society for Reproductive Biology Founders’ Lecture 2009. Preparing fertile soil: the importance of endometrial receptivity[J]. Reprod Fertil Dev, 2009, 21(7):923-934.
[7]Murray MJ, Lessey BA, Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis[J]. Semin Reprod Endocrinol, 1999, 17(3): p. 275-290.
[8]Zhang XY, Li M, Sun K, et al. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma [J]. Oncotarget, 2015, 6(1):101-115.
[9]Li M, Li Z, Liang C, et al. Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.[J]. Oncol Rep, 2014, 32(5):2183-2190.
[10]Zhang Y, Hao H, Zhao S, et al. Downregulation of GRIM-19 promotes growth and migration of human glioma cells[J]. Cancer Sci, 2011, 102(11):1991-1999.
[11]Zhou Y, Li M, Wei Y, et al. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers[J]. J Interferon Cytokine Res, 2009, 29(10):695-703.
[12]Zhou T, Chao L, Rong G, et al. Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas [J]. Hum Pathol, 2013, 44(9):1773-1779.
[13]Gong LB, Luo XL, Liu SY, et al. Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma[J]. Ai Zheng, 2007,26(7):683-687.
[14]Singh M, Chaudhry P, Asselin E. (2011) Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors [J]. J Endocrinol, 2011,210(1):5-14.
[15]Cha J, Sun X, Dey SK.. Mechanisms of implantation: strategies for successful pregnancy [J]. Nat Med, 2012, 18(12):1754-1767.
[16]Cui WJ,Deng XH,Chao L, et al. Expression of GRIM-19 and its effects in preimplantation embryo of mice [J]. Acta Anatomica Sinica, 2013,44(1):97-101. (in Chinese)
崔文娟,邓晓惠,晁岚,等.GRIM-19在小鼠植入前胚胎中的表达及其作用[J].解剖学报,2013,44(1):97-101.
[17]Nallar SC, Kalakonda S, Lindner DJ, et al. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis[J]. J Biol Chem, 2013, 288(11):7930-7941.
[18]Chen Y, Lu H, Liu Q,et al.Function of GRIM19, a mitochondrial respiratory chain complex I protein, in innate immunity[J].Biol Chem, 2012, 287(32):27227-27235.
[19]Pawar S, Starosvetsky E, Orvis GD, et al. STAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantation[J]. Mol Endocrinol, 2013, 27(12):1996-2012.
[20]Lee JH, Kim TH, Oh SJ, et al. Signal transducer and activator of transcription-3 (Stat3) plays a critical role in implantation via progesterone receptor in uterus[J].FASEB J, 2013, 27(7):2553-2563.
[21]Moon YM, Lee J, Lee SY, et al. Gene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of th17 and treg cells. [J]. Arthritis Rheumatol, 2014, 66(3):569-578.
[22]Cheng Y, Zhang HY, Zhou Y, et al. Decreased expression of GRIM-19 and its association with high-risk HPV infection in cervical squamous intraepithelial neoplasias and cancer. [J]. Clin Invest Med, 2014, 37(2):E77-84.
[23]Gaunt G, Ramin K. Immunological tolerance of the human fetus[J]. Am J Perinatol, 2001, 18(6): 299-312.
[24]Bulla R, Fischetti F, Bossi F, et al. Feto-matemal immune interaction at the placental level[J]. Lupus, 2004, 13(9): 625-629
[25]Aluvihare VR, Kallikourdis M, Betz AG. Tolerance, suppression and the fetal allograft[J]. J Mol Med, 2005, 83(2): 88-96.
[26]Daher S de Arruda Gerardi K, Blotta MH, et al. Cytokines in recurrent pregnancy loss[J]. J Reprod Immunol, 2004, 62(1-2): 151-157.
[27]Zhang J, Wang HX, Zhou JH, et al.Changes of TH1/TH2-type cells in decidua[J].Journal of Sichuan University (Medical Sciences Edition), 2005,36(4):574-575. (in Chinese)
张静,王红霞,周建慧,等.自然流产患者蜕膜组织Thl/Th2型细胞的变化[J].四川大学学报(医学版),2005,36(4):574-575.
[28]Dimitriadis E, Sharkey AM, Tan YL, et al. Immunolocalisation of phosphorylated STAT3,interleukin11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window[J]. Reprod Biol Endocrinol,2007, 5:44. |